Norinchukin Bank The Purchases 8,822 Shares of CVS Health Corporation $CVS

Key Points

• Norinchukin Bank The increased its stake in CVS Health Corporation by 15.5% in Q1, bringing its total holdings to $4.45 million valued at 65,668 shares.
• CVS Health's recent earnings report showed earnings per share (EPS) of $1.81, exceeding estimates, with revenues reaching $98.92 billion, an 8.4% increase year-over-year.
• CVS reportedly has a consensus rating of "Buy" from analysts, with target prices ranging from $74.00 to $82.00, reflecting positive sentiment towards the company's performance.

Norinchukin Bank The raised its stake in CVS Health Corporation (NYSE:CVS - Free Report) by 15.5% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 65,668 shares of the pharmacy operator's stock after acquiring an additional 8,822 shares during the period. Norinchukin Bank The's holdings in CVS Health were worth $4,449,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the stock. Price T Rowe Associates Inc. MD boosted its position in shares of CVS Health by 14.2% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 13,366,403 shares of the pharmacy operator's stock worth $600,019,000 after buying an additional 1,660,321 shares during the period. MGO One Seven LLC raised its stake in CVS Health by 4.2% during the 4th quarter. MGO One Seven LLC now owns 21,484 shares of the pharmacy operator's stock valued at $964,000 after purchasing an additional 868 shares during the period. Coppell Advisory Solutions LLC raised its stake in CVS Health by 17.3% during the 4th quarter. Coppell Advisory Solutions LLC now owns 1,282 shares of the pharmacy operator's stock valued at $56,000 after purchasing an additional 189 shares during the period. Syon Capital LLC raised its stake in CVS Health by 3.4% during the 4th quarter. Syon Capital LLC now owns 7,526 shares of the pharmacy operator's stock valued at $338,000 after purchasing an additional 247 shares during the period. Finally, Adage Capital Partners GP L.L.C. grew its holdings in shares of CVS Health by 2.3% during the 4th quarter. Adage Capital Partners GP L.L.C. now owns 1,192,774 shares of the pharmacy operator's stock valued at $53,544,000 after acquiring an additional 26,738 shares in the last quarter. 80.66% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at CVS Health

In other CVS Health news, Director Guy P. Sansone purchased 1,570 shares of the company's stock in a transaction that occurred on Thursday, June 5th. The stock was purchased at an average price of $63.70 per share, with a total value of $100,009.00. Following the completion of the transaction, the director directly owned 12,007 shares of the company's stock, valued at approximately $764,845.90. This trade represents a 15.04% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 1.22% of the stock is owned by company insiders.

CVS Health Stock Performance

Shares of CVS traded down $0.08 during trading hours on Monday, reaching $71.22. 4,665,750 shares of the company traded hands, compared to its average volume of 9,804,958. The stock's fifty day moving average is $65.50 and its 200 day moving average is $65.25. The stock has a market cap of $90.33 billion, a P/E ratio of 19.89, a price-to-earnings-growth ratio of 0.79 and a beta of 0.58. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.62 and a current ratio of 0.80. CVS Health Corporation has a 1-year low of $43.56 and a 1-year high of $72.51.

CVS Health (NYSE:CVS - Get Free Report) last announced its quarterly earnings data on Thursday, July 31st. The pharmacy operator reported $1.81 EPS for the quarter, beating analysts' consensus estimates of $1.46 by $0.35. The business had revenue of $98.92 billion during the quarter, compared to analyst estimates of $94.87 billion. CVS Health had a net margin of 1.17% and a return on equity of 10.51%. The firm's revenue for the quarter was up 8.4% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.83 earnings per share. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. Equities research analysts anticipate that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, August 1st. Stockholders of record on Tuesday, July 22nd were given a dividend of $0.665 per share. The ex-dividend date of this dividend was Tuesday, July 22nd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.7%. CVS Health's dividend payout ratio is currently 74.30%.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on CVS shares. Robert W. Baird upgraded shares of CVS Health from a "neutral" rating to an "outperform" rating and boosted their price target for the company from $71.00 to $82.00 in a report on Thursday, August 14th. Baird R W upgraded shares of CVS Health from a "hold" rating to a "strong-buy" rating in a report on Thursday, August 14th. Wells Fargo & Company restated an "overweight" rating and set a $84.00 price target (up from $76.00) on shares of CVS Health in a report on Tuesday, May 6th. Barclays upped their price objective on shares of CVS Health from $79.00 to $80.00 and gave the stock an "overweight" rating in a report on Friday, August 1st. Finally, Bernstein Bank decreased their price objective on shares of CVS Health from $78.00 to $72.00 and set a "market perform" rating for the company in a report on Wednesday, July 16th. Two research analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating and one has given a Hold rating to the company. According to data from MarketBeat.com, the company has a consensus rating of "Buy" and a consensus target price of $76.67.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.